Trexquant Investment LP Neuronetics, Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.87 - $6.59 $84,335 - $143,609	-21,792 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.22 - $15.54 $27,504 - $68,717	4,422 Added 25.46%	21,792 $143,000
Q2 2021 Aug 12, 2021	BUY	$10.15 - $17.25 $176,305 - $299,632	17,370 New	17,370 $278,000
Q1 2020 May 08, 2020	SELL	$1.28 - $4.5 $66,426 - $233,532	-51,896 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$4.03 - $9.22 $159,463 - $364,826	39,569 Added 320.99%	51,896 $233,000
Q3 2019 Nov 08, 2019	BUY	$8.31 - $13.03 $102,437 - $160,620	12,327 New	12,327 $102,000

10M

24.1K

200

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $125M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.